A composition in aqueous solution includes insulin and at least one substituted anionic compound chosen from substituted anionic compounds consisting of a backbone formed from a discrete number u of between 1 and 8 (1≤u≤8) of identical or different saccharide units, linked via identical or different glycoside bonds, the saccharide units being chosen from the group consisting of hexoses, in cyclic form or in open reduced form, said compound comprising partially substituted carboxyl functional groups, the unsubstituted carboxyl functional groups being salifiable. A pharmaceutical formulation including the composition is also set forth.

Disclosed are surgical hydrogels derived from the combination of chitosan derivative and aldehyde-derivatised dextran polymers in combination with a humectant for use as surgical wound packing materials or stents. Also disclosed are sterile kits comprising the precursor components of the surgical hydrogels. Also disclosed are methods of sterilizing the kits and individual components thereof for preparing the hydrogels.

Compositions are disclosed herein comprising a graft copolymer that comprises: (i) a backbone comprising dextran that has been modified with about 1%-25% alpha-1,2 branches, and (ii) one or more alpha-1,3-glucan side chains comprising at least about 50% alpha-1,3 glycosidic linkages. Further disclosed are reactions for producing such graft copolymers, as well as their use in derivatives, films and various other applications.

Metal contaminants may be problematic in a number of industries, particularly in the mining industry. Fines production and dust control may be similarly problematic in many industries, including the mining industry. Reaction products formed from a saccharide polymer and diallyldimethylammonium chloride (DADMAC) under room temperature to heating conditions in the presence of a hydroxide base or a radical initiator may be effective for promoting removal of metal contaminants from clay-containing substances, such as through froth flotation. The reaction products may also be effective for mitigating fines production and providing dust control by forming a coating upon a plurality of particulates.

The present disclosure provides a heteropoly oligosaccharide and an application thereof in improving plant disease resistance. The heteropoly oligosaccharide includes seven D-glucose residues and one D-galactose residue. Each heteropoly oligosaccharide molecule comprises R.sub.1 and R.sub.2, R.sub.1 being H or a monomolecular pyruvate group, R.sub.2 being H or a monomolecular succinyl group, and the structure thereof is represented as follows:

Fluid contaminants may be prevalent in many industries, such as the mining industry. Functionalized saccharide polymers comprising two or more monosaccharide units linked by glycosidic bonds and having a portion of the monosaccharide units oxidatively opened and functionalized with at least one aminocarboxylic acid covalently bound through nitrogen at a site of oxidative opening may be utilized in conjunction with fluid remediation processes, such as froth flotation. In non-limiting examples, the functionalized saccharide polymers may also be useful for promoting dust control, particulate coating, clay stabilization, and various subterranean treatment operations. Glycine represents one example of an aminocarboxylic acid that may be covalently bonded through nitrogen at a site of oxidative opening.

The present invention relates to a method of preparing a hierarchically porous polymer and a hierarchically porous polymer prepared thereby. The method comprises the steps of: (a) polymerizing an external oil phase of a high internal phase emulsion (HIPE) consisting aqueous droplets to produce a cross-linked block copolymer; (b) obtaining a macroporous polymer with interconnected macropores by removing the aqueous droplets; and (c) treating the obtained porous polymer with a base, thereby obtaining a hierarchically porous polymer having three-dimensional mesopores formed in the macroporous walls. According to the method, the macropore size and mesopore size of the hierarchically porous polymer can all be controlled. The hierarchically porous polymer prepared by the method can easily separate polymers having different sizes, and thus is highly useful in the polymer separation field.

Therapeutic compositions and/or formulations are provided, comprising: at least one cross-linked protein matrix, wherein the at least one cross-linked protein matrix comprises at least one protein residue and at least one saccharide-containing residue, and methods of producing the same. The cross-linked protein matrix may be derived from cross-linking a full length or substantially full length protein, such as tropoelastin, elastin, albumin, collagen, collagen monomers, immunoglobulins, insulin, and/or derivatives or combinations thereof, with a saccharide containing cross-linking agent, such as a polysaccharide cross-linking agent derived from, for example, hyaluronic acid or a cellulose derivative. The therapeutic compositions may be administered topically or by injection. The present disclosure also provides methods, systems, and/or kits for the preparation and/or formulation of the compositions disclosed herein.

Disclosed herein is method for conjugating a metal chelating agent to a functionalized dextran by reacting a chelator with an aminated dextran backbone, where the chelator comprises a one, and only one, derivatized carboxylic acid group to form a chelator-dextran complex. In certain aspects, the dextran-chelator complex is substantially free of intra- or intermolecular crosslinking. In certain aspects, the functionalized dextran is an amine dextran, an alkynyl dextran, or a thiol dextran. In exemplary implementations, the functionalized dextran is an amine dextran. In further embodiments, one and only one carboxylic acid group on the chelating agent is derivatized as a N-hydroxysuccinimide (NHS) ester.

Compositions and methods of using these compositions that can include a targeting moiety and a therapeutic agent are described herein. These compositions can be used for diagnosing and/or treating flaviviridae-family viruses including Zika virus, dengue virus, and yellow fever.